Our firm

Evolve HealthCare Partners (“EHP”) is a mid-market private equity firm founded by former international C-level healthcare executives and investors that aims to partner with European healthcare companies with growth and/or strategic repositioning ambitions, both organically or via M&A.

EHP’s approach to value creation is operationally focused and hands-on, thus well-placed to apply differentiated investment strategies focused on improving the growth profile of companies in the healthcare space and being able to generate above-industry average returns to investors in a sector that continues to progress and inspire.

Our focus

We are a healthcare specialist investor and as such we focus on the European healthcare space and are able to invest in all healthcare segments (except biotech). We believe this approach across the healthcare industry delivers improved investment decisions given the clear trend towards convergence of stakeholders across the sector and the increasingly high connectivity between its segments.

Specialty Pharma

Specialty Generics
Orphan diseases
Biosimilars
Consumer healthcare
Nutraceuticals
New delivery mechanisms
R&D services
Respiratory
Ophthalmology
Aesthetics
Neurology
Musculoskeletal
Oncology
Rheumatology
Anti-infectives
Cardiovascular
Haematology
Endocrinology

Healthcare Services

Specialised labs
GP/poly-clinics
Imaging centers
Contract manufacturing
Ambulatory surgery
Sterilization/ waste
Dental labs
Clinical labs
Elderly care
Ophthalmic clinics
Contract research
Dental clinics
Home care
Mental health clinics
Pharmacies
Cosmetic clinics
Obesity clinics
Derma clinics
Contract sales
In-Vitro Fertilsation

Medtech

Monitoring
Electronic Medical Records
Hospital Information Systems
Image Archiving & Communication Systems
Procedure trays
Disposables
Orthopedic
Cardio
Woundcare
Ophthalmology
Diagnostics
Imaging
Surgical
Non-surgical
Dialysis

Healthcare IT

Care management
Telehealth / Virtual Care
Supply chain IT
Clinical Decision Support
Population health analytics
Data aggregation
Result interpretation
Virtual clinical trials
Patient throughput solutions
Patient Engagement (testing, portals, e-learning, patient health record)
Trial performance software
Integrated eClinical
eCOA
Electronic medical records
Electronic master file
Revenue cycle management
Interoperability solutions

Our values

EHP believes that supporting mid-size European healthcare companies in their growth ambitions will positively impact patient’s health and quality of life lives and thus creating value for society as a whole.

In addition, it will contribute to the long-term sustainability of the European healthcare systems by improving operational efficiencies and thus ultimately reducing the aggregated cost of healthcare.

Environmental, Social and Governance (“ESG”) principles are at the heart of EHPs investment and management philosophy, allowing us to focus on opportunities that best serve the issues of healthcare sustainability while rendering attractive returns to investors.

EHP will adhere to the “UN Principles for Responsible Investment” which aims to fully integrate ESG principles into mainstream investment decision-making and ownership practices, providing a framework for the integration of responsible business conduct into investment strategies.

At EHP, everything we do is always anchored and influenced by the core values we strongly believe in. The partnering approach, integrity, excellence and long-term focus are embedded in they way we behave and operate with our people, our portfolio companies and our investors. We are great believers that the “what” you do in life is important, but what really makes the difference is “how” you do things. That is the only way to have a sustainable impact on people and society.

Our approach

We aim to be hands on investors, actively collaborating with founders and managers to jointly define and execute on their growth ambitions. As former C-level healthcare executives and investors with a strong operational track record, we believe that our ability to understand businesses and value creation levers, and to successfully deliver on promises identified in the strategic plan is significantly improved. Given the diverse capabilities of the founding team, we believe are well position to identify pockets of value that otherwise would not be possible.

Our capabilities in corporate strategy & development, commercial operations and innovation strategy allows us to act on the key value creation levers that can change the growth profile of the companies we partner with. By doing so, we believe we ensure the long-term sustainability of the companies we partner with and thus having a social impact on what is our passion, sustainable healthcare. Our international network of partners and contacts can provide a further driver for facilitating growth and operational efficiencies. We seek to align with our partners through a balanced shareholder agreement as well as board representation, guaranteeing alignment of interests from day one.

Our investment strategy

EHP seeks to partner with mid-sized European healthcare companies with revenues up to €200m and EBITDAs up to €50m. Our typical equity tickets will be in the €20-50m range, but with the flexibility to secure bigger equity needs with our co-investors.

EHP vision is focused on the quality of the management team and the asset, thus we are very flexible in the financial structures we apply. In this regard, we tailor such structures to the specific opportunities and as such we can do both 100% acquisition, majorities and minorities. Our partnering approach is what really differentiates us and as such we design the best financial structures together with shareholders and management teams.